Sign in
Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)
Journal article   Open access  Peer reviewed

Phase II study of neoadjuvant therapy with docetaxel, cisplatin, panitumumab, and radiation therapy followed by surgery in patients with locally advanced adenocarcinoma of the distal esophagus (ACOSOG Z4051)

A.C Lockhart, C.E Reed, P.A Decker, B.F Meyers, M.K Ferguson, A.R Oeltjen, J.B Putnam, S.D Cassiv, A.J Montero, T.E Schefter, …
Annals of oncology, Vol.30(2), pp.345-345
2019-02
PMCID: PMC6386025
PMID: 29390067
url
https://doi.org/10.1093/annonc/mdx813View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.95 Gastrointestinal & Esophageal Diseases
1.95.756 Esophageal Cancer
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details